IL6 and systemic inflammatory response syndrome: This inflammatory activation further triggers the release of inflammatory mediators, such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), which exacerbate local pancreatic inflammation and may induce systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) [3].